Gray, H. ., Bell-McGuinn, K. ., Fleming, G. ., Cristea, M. ., Xiong, H. ., Sullivan, D. ., … Martin, L. . (2018). Phase I combination study of the PARP inhibitor veliparib plus carboplatin and gemcitabine in patients with advanced ovarian cancer and other solid malignancies. Gynecologic Oncology. https://doi.org/10.1016/j.ygyno.2017.12.029 (Original work published 2018)